Category: Diagnostic Technologies

Diagnostic Technologies

Questions Labs Are Asking Before Investing in Hemostasis Systems

As laboratories weigh new hemostasis investments, Sysmex experts discuss the questions that can help guide system selection.

Diagnostic Technologies

Hair Drug Test Positivity Reaches 19.1% Among US Workers

Hair drug test positivity among US workers rose to 19.1% in 2025, a 46% increase since 2021, with marijuana accounting for over half of positive results, according to the 2026 Quest Diagnostics Drug Testing Index.

Diagnostic Technologies

Experts Call for End to Routine ‘Corrected’ Calcium Reporting

A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.

Anatomic Pathology

AI Pathology Tool Predicts Immunotherapy Success in Rare Cancers

Researchers at MD Anderson have developed an AI-based pathology tool that predicts immunotherapy response in rare cancers by analyzing immune cell changes in biopsies, according to a Journal for ImmunoTherapy of Cancer study.

Digital Pathology

Spotlight Medical Receives European Approval for AI Breast Cancer Test

Spotlight Medical’s myStage Dx AI breast cancer test has received CE marking under EU IVDR, enabling adoption in European oncology and pathology labs for recurrence risk assessment in ER+/HER2- early breast cancer patients.

Clinical Chemistry

FDA Clears New Heart Disease Risk Test for Clinical Labs

The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.

Flow Cytometry

Single-Cell Sequencing May Identify New Exercise Biomarkers

Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.

Hematology & Serology

Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors

The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.

Immunoassay

Roche Receives CE Mark for Tuberculosis Blood Test

The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.

Mass Spectrometry

University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer

The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.

Microbiology

Study to Evaluate One-Hour Testing for Drug-Resistant Infections

The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.

Molecular Diagnostics

Bio-Rad Releases New Quality Control Kits for Cell and Gene Therapy

Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Urine Metabolite Test Shows Potential for Autism Risk Screening

The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.